Industry News
First-of-a-kind once daily pill given regulatory green light for patients with rare type of skin cancer, UK
Aug 13, 2013
Patients with advanced basal cell carcinoma who are not suitable for surgery or radiotherapy, could benefit from Erivedge (vismodegib) which is available following conditional EMA authorisation for use in the UK and listing on the national Cancer Drugs Fund (CDF)... Read More
Making tumor-targeting T cells in a dish
Aug 13, 2013
A method for producing from stem cells a large quantity of human immune cells capable of killing tumor cells in mice is presented in a paper published online this week in Nature Biotechnology. The approach may make it easier to implement cancer 'immunotherapies' - a suite of treatments that activate the immune system to attack tumors... Read More
'Smart' nanoparticles designed to improve drug delivery, DNA self-assembly
Aug 13, 2013
A team of chemists in SU's College of Arts and Scientists has used a temperature-sensitive polymer to regulate DNA interactions in both a DNA-mediated assembly system and a DNA-encoded drug-delivery system. Their findings, led by Associate Professor Mathew M... Read More
Novel biological pathway leads to successful treatment of triple negative breast cancer
Aug 13, 2013
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually... Read More
Multipronged approach attacks breast cancer cells, blocking the growth of cancer-supporting blood vessels, stimulating antitumor immune response
Aug 13, 2013
A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer cells... Read More
Geneticists confirm herbal remedy carcinogen
Aug 12, 2013
In a study that identifies the striking genetic changes caused by a herb compound, scientists have found a direct link between aristolochic acid - used in a traditional herbal remedy - and upper urinary tract cancers... Read More
Pomalidomide Celgene® - (pomalidomide) licensed for use in the UK for the treatment of adults with relapsed/refractory multiple myeloma
Aug 12, 2013
Celgene has confirmed that Pomalidomide Celgene® - (pomalidomide), a new oral blood cancer therapy, has been granted Marketing Authorisation by the European Medicines Agency and is now available in the UK and Ireland... Read More
Scientists identify biomarker to predict immune response risk after stem cell transplants
Aug 12, 2013
Researchers from Indiana University, the University of Michigan, the Fred Hutchinson Cancer Research Center and the Dana-Farber Cancer Institute have identified and validated a biomarker accessible in blood tests that could be used to predict which stem cell transplant patients are at highest risk for a potentially fatal immune response called graft-versus-host disease... Read More
Occupational cancer now leading cause of compensated work-related deaths in Canada
Aug 12, 2013
Occupational cancer is now the leading cause of compensated work-related deaths in Canada, surpassing those from accidents and injuries, according to new research published today in CMAJ Open... Read More
Ovarian cancer sniffed out by dogs
Aug 12, 2013
Researchers are looking to create a breakthrough method of detecting ovarian cancer - by using dogs to sniff out the disease. A group of researchers collaborated to investigate using canine olfaction and chemical and nanotechnology analysis as a means of detecting early-stage ovarian cancer... Read More
Previous Page Next Page